Myriad Genetics | MYGN - Capitalização De Mercado

Preço das Ações
4.78
Mudança Diária
-0.01 -0.21%
Mensal
2.14%
Anual
-35.58%
Q2 Previsão
4.68




Capitalização De Mercado Alterar Data
Agilent USD 37.86B 3.64B 2025-12
Becton, Dickinson and Co. USD 55.29B 1.64B 2025-12
Bio-Rad Laboratories USD 8.21B 601M 2025-12
Bruker USD 7.16B 2.23B 2025-12
Danaher USD 140.45B 11.98B 2026-04
Illumina USD 20.62B 6.53B 2025-12
J&J USD 561.65B 17.5B 2026-04
Mettler Toledo International USD 28.48B 3.19B 2025-12
Myriad Genetics USD 575M 98M 2025-12
OraSure Technologies USD 174M 61M 2025-12
Pacific Biosciences Of California USD 565M 180M 2025-12
Quest Diagnostics USD 22.89B 1.19B 2026-04
Quidel USD 1.99B 66M 2025-12
Repligen USD 9.22B 1.7B 2025-12
Revvity USD 10.97B 1.21B 2025-12
Standard Biotools USD 492M 5M 2025-12
Thermo Fisher Scientific USD 177.96B 4.7B 2026-04
Veracyte USD 3.33B 627M 2025-12
Waters USD 22.61B 5.25B 2025-12